- Home
- CWST vs AXSM Comparison
CWST vs AXSM Comparison
Compare CWST & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWST
- AXSM
- Stock Information
- Founded
- CWST 1975
- AXSM 2012
- Country
- CWST United States
- AXSM United States
- Employees
- CWST N/A
- AXSM N/A
- Industry
- CWST Environmental Services
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- CWST Utilities
- AXSM Health Care
- Exchange
- CWST Nasdaq
- AXSM Nasdaq
- Market Cap
- CWST 5.8B
- AXSM 5.9B
- IPO Year
- CWST 1997
- AXSM 2015
- Fundamental
- Price
- CWST $89.54
- AXSM $121.35
- Analyst Decision
- CWST Buy
- AXSM Strong Buy
- Analyst Count
- CWST 8
- AXSM 19
- Target Price
- CWST $117.50
- AXSM $174.26
- AVG Volume (30 Days)
- CWST 596.2K
- AXSM 471.2K
- Earning Date
- CWST 10-29-2025
- AXSM 11-03-2025
- Dividend Yield
- CWST N/A
- AXSM N/A
- EPS Growth
- CWST N/A
- AXSM N/A
- EPS
- CWST 0.18
- AXSM N/A
- Revenue
- CWST $1,721,548,000.00
- AXSM $495,033,000.00
- Revenue This Year
- CWST $20.21
- AXSM $63.62
- Revenue Next Year
- CWST $7.69
- AXSM $55.72
- P/E Ratio
- CWST $503.94
- AXSM N/A
- Revenue Growth
- CWST 20.35
- AXSM 69.83
- 52 Week Low
- CWST $85.21
- AXSM $75.56
- 52 Week High
- CWST $121.24
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- CWST 41.92
- AXSM 56.85
- Support Level
- CWST $89.00
- AXSM $117.30
- Resistance Level
- CWST $94.17
- AXSM $124.13
- Average True Range (ATR)
- CWST 2.57
- AXSM 3.25
- MACD
- CWST 0.34
- AXSM 0.01
- Stochastic Oscillator
- CWST 25.72
- AXSM 64.96
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.